TABLE 1.
Baseline characteristics of study participants (n = 219)
| Age (years) | 29.62 ± 8.6 |
| Parity | |
| 0 | 130 (59.4) |
| 1 | 15 (6.8) |
| ≥2 | 74 (33.8) |
| Marital status | |
| Single | 142 (64.8) |
| Married/permanent relationship | 77 (35.2) |
| Background diseases | 22 (10.1) |
| Endocrine disorders | 7 (3.2) |
| GI diseases | 3 (1.4) |
| Pulmonary diseases | 2 (0.9) |
| Neurologic disorders | 1 (0.4) |
| Cardio‐metabolic diseases | 4 (1.8) |
| Regular medications | |
| SNRI\SSRI | 17 (7.8) |
| Levothyroxine sodium | 4 (1.8) |
| Ventolin | 3 (1.4) |
| Other | 8 (3.6) |
| Hormonal treatment | |
| OCP | 45 (20.5) |
| Levonorgestrel IUD | 12 (5.5) |
| Non‐hormonal IUD | 11 (5.0) |
| Other | 4 (1.4) |
Note: Values are presented as mean ± standard deviation or as number (%).
Abbreviations: GI, gastrointestinal disease; IUD, intrauterine device; OCP, oral contraceptive pill; SNRI, serotonin‐norepinephrine reuptake Inhibitors; SSRI, selective serotonin reuptake inhibitor.